Joan Mannick, MD
Head of Research & Development at Life Biosciences, USA
Dr. Joan Mannick is an expert in the field of aging, is the Head of Research & Development at Life Biosciences.
Most recently, she served as co-founder and CMO at resTORbio, recently acquired by Adicet Bio. Before that, she was the executive director of the New Indications Discovery Unit at Novartis Institutes of Biomedical Research, where she led the clinical-stage mTORC1 program licensed by resTORbio. Prior to joining Novartis in 2010, Dr. Mannick was a medical director at Genzyme Corporation leading an investigator-sponsored program for early stage oncology products. She has served as a faculty member at Harvard Medical School and University of Massachusetts Medical School. Her NIH-sponsored laboratory focused on the role of protein S-nitrosylation in physiology and pathophysiology.
Dr. Mannick received her BA from Harvard College and her MD from Harvard Medical School. She completed her residency in Internal Medicine at Brigham and Women’s Hospital and an Infectious Disease fellowship as part of the Harvard Combined Infectious Disease Program. She is board-certified in Internal Medicine and Infectious Diseases.